Trial intelligence / Profile preview

Growth hormone treatment in short prepubertal children born small for gestational age

NL-OMON24733Recruiting

Sponsor
Erasmus MC
Start
Mar 2002
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of somatropin in Short stature in children born small for gestational age (3 arms), sponsored by Erasmus MC. Primary endpoints: Insulin sensitivity, Body composition and 1 more. Started Mar 2002; status: recruiting.

02

Drugs

somatropin
03

Conditions

Short stature in children born small for gestational age

Beyond the preview

Go deeper on NL-OMON24733.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON24733.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call